J&J | JNJ - Selling And Administration Expenses

Stock Price
243.45
Daily Change
-1.10 -0.45%
Monthly
11.39%
Yearly
55.91%
Q1 Forecast
232.62

J&J reported $6.75B in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Abbott USD 3.13B 125M Dec/2025
Amgen USD 1.94B 237M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Baxter International USD 761M 53M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
CONMED USD 166.76M 26.42M Dec/2025
Cooper Companies USD 419.2M 12M Sep/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 602.9M 88.3M Dec/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Globus Medical USD 313.6M 9.98M Sep/2025
Hologic USD 2.5B 2.24B Dec/2025
Insulet USD 315.2M 61.9M Sep/2025
Integra LifeSciences USD 169.05M 10.84M Sep/2025
Intuitive Surgical USD 687.1M 113.8M Dec/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Merck USD 2.85B 215M Dec/2025
Merit Medical Systems USD 107.38M 5.72M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 94.52M 1.47M Sep/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Vertex Pharmaceuticals USD 487M 41.9M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025
Zoetis USD 619M 40M Dec/2025